12:02
Traffic jam:   4
$
92.5919
100.2704

Permission to use the AstraZeneca's vaccine is in question

30 November 2020
2923
2 min.
7
Permission to use the AstraZeneca's vaccine is in question

Will AstraZeneca vaccine be allowed to be used?

Despite all the assurances of AstraZeneca Pascal Soriot, CEO of AstraZeneca, that the additional study should not slow down obtaining regulatory approvals for the use of COVID-19 vaccine, a number of questions have arisen about the effectiveness of the drug being developed by the company together with Oxford University, Bloomberg writes.

In order to clarify the uncertainty and confusion surrounding the positive results of the current study, the vaccine will be sent to a new trial to confirm its stated 90 per cent effectiveness.


It should be noted that after Astra Zeneca admitted that the lower dosage level, which in fact proved to be even more effective, was the result of a mistake. A day after the release of the 90 percent vaccine efficacy data, the head of the American vaccine programme Operation Warp Speed said that the higher efficacy regime had been tested on younger, and therefore stronger, patients.

P. Soriot said: "I think there will be another global study, but it will go faster because we know that the effectiveness of the drug is high, so we need fewer patients".

Also, the UK Health Secretary, Matthew Hancock, has asked the regulator to issue a permit earlier than his EU colleague and to approve the delivery of AstraZeneca vaccine to speed up its introduction in the country before the end of the year, when the UK will end its transition period after Brexit.

The current rule allows the UK regulator to allow temporary deliveries of the vaccine even before the European Medicines Agency authorises it, if the data on the vaccine tests are sufficiently reliable. It is now up to the results of the tests alone.

With regard to authorising the vaccine in the USA, the Food and Drug Administration (FDA) may delay approval, firstly because the vaccine tests are not carried out in America, and secondly because there are questions about the results.

Astra shares fell 0.8 per cent on Friday morning on the London Stock Exchange, resulting in a fall of around 8 per cent this week.

Persons2 and Companies5 in the news

Secretary of State for Health and Social Care
1 place
Chief Executive Officer of AstraZeneca
2 place
AstraZeneca
4 place
Bloomberg L.P.
5 place
Section:

Discussion

Rating companies
Tesla
14 Mention
Instagram
13 Mention
JP Morgan Chase
12 Mention
Walt Disney Company
12 Mention
Ford Motor Company
10 Mention
Netflix
10 Mention
Amazon
9 Mention

NEW YORK NEWS

News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director
Population
8112610408
Died this year
14238226
Born this year
35028556